These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25099412)

  • 21. [Management of occupational health for adverse health effects of beryllium and its compounds in workplaces - Recent trends and issues in Japan].
    Toyooka T; Koda S
    Sangyo Eiseigaku Zasshi; 2021 Mar; 63(2):31-42. PubMed ID: 32788509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beryllium workers' health risks.
    Newman LS; Maier LA; Martyny JW; Mroz MM; VanDyke M; Sackett HM
    J Occup Environ Hyg; 2005 Jun; 2(6):D48-50. PubMed ID: 16020086
    [No Abstract]   [Full Text] [Related]  

  • 23. Occupational exposure to beryllium and cancer risk: a review of the epidemiologic evidence.
    Boffetta P; Fryzek JP; Mandel JS
    Crit Rev Toxicol; 2012 Feb; 42(2):107-18. PubMed ID: 22276590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era.
    Mikulski MA; Leonard SA; Sanderson WT; Hartley PG; Sprince NL; Fuortes LJ
    Am J Ind Med; 2011 Mar; 54(3):194-204. PubMed ID: 21298695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beryllium exposure and chronic beryllium disease.
    Infante PF; Newman LS
    Lancet; 2004 Feb; 363(9407):415-6. PubMed ID: 14962519
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence of beryllium sensitization among aluminium smelter workers.
    Taiwo OA; Slade MD; Cantley LF; Kirsche SR; Wesdock JC; Cullen MR
    Occup Med (Lond); 2010 Oct; 60(7):569-71. PubMed ID: 20610489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients.
    Müller-Quernheim J; Gaede KI; Fireman E; Zissel G
    Eur Respir J; 2006 Jun; 27(6):1190-5. PubMed ID: 16540500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic beryllium disease: risk from low-level exposure.
    Redlich CA; Welch LS
    Am J Respir Crit Care Med; 2008 May; 177(9):936-7. PubMed ID: 18434330
    [No Abstract]   [Full Text] [Related]  

  • 29. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3.
    Kreiss K; Mroz MM; Newman LS; Martyny J; Zhen B
    Am J Ind Med; 1996 Jul; 30(1):16-25. PubMed ID: 8837677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mortality study of beryllium workers.
    Boffetta P; Fordyce TA; Mandel JS
    Cancer Med; 2016 Dec; 5(12):3596-3605. PubMed ID: 27766788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beryllium.
    Deubner DC
    J Occup Environ Hyg; 2005 Oct; 2(10):D74-6; author reply D76-8. PubMed ID: 16174633
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects.
    Fireman E; Lerman Y; Stark M; Pardo A; Schwarz Y; Van Dyke MV; Elliot J; Barkes B; Newman L; Maier L
    J Occup Environ Hyg; 2014; 11(12):809-18. PubMed ID: 24856577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of beryllium sensitized workers from a single employer.
    Duggal M; Deubner DC; Curtis AM; Cullen MR
    BMC Public Health; 2010 Jan; 10():5. PubMed ID: 20047684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization.
    McCanlies EC; Schuler CR; Kreiss K; Frye BL; Ensey JS; Weston A
    J Occup Environ Med; 2007 Apr; 49(4):446-52. PubMed ID: 17426528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.
    Amicosante M; Berretta F; Rossman M; Butler RH; Rogliani P; van den Berg-Loonen E; Saltini C
    Respir Res; 2005 Aug; 6(1):94. PubMed ID: 16098233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beryllium hypersensitivity and chronic beryllium lung disease.
    Santo Tomas LH
    Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beryllium exposure: dermal and immunological considerations.
    Day GA; Stefaniak AB; Weston A; Tinkle SS
    Int Arch Occup Environ Health; 2006 Feb; 79(2):161-4. PubMed ID: 16231190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.
    Cullen MR; Kominsky JR; Rossman MD; Cherniack MG; Rankin JA; Balmes JR; Kern JA; Daniele RP; Palmer L; Naegel GP
    Am Rev Respir Dis; 1987 Jan; 135(1):201-8. PubMed ID: 3492158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Illness absences among beryllium sensitized workers.
    Watkins JP; Ellis ED; Girardi DJ; Cragle DL; Richter BS
    Am J Public Health; 2014 Nov; 104(11):e165-9. PubMed ID: 25211750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.